Vera Therapeutics(VERA.US)

Last Updated 19:00:00 ET
longbridge loading

UBS Group AG Boosts Position in Vera Therapeutics, Inc. $VERA

Market Beat·
US
VERA
-3.20%
US
XBI
-0.69%
US
SBIO
-1.24%
Market Beat·
US
VERA
-3.20%
US
XBI
-0.69%
US
SBIO
-1.24%

Vera Therapeutics: Buy Rating Reiterated on Strong Atacicept Outlook and Launch Readiness; $73 Price Target Maintained

Tip Ranks·
US
VERA
-3.20%
US
PBE
+0.11%
US
BBH
+0.68%
Tip Ranks·
US
VERA
-3.20%
US
PBE
+0.11%
US
BBH
+0.68%

Vera Therapeutics (NASDAQ:VERA) Posts Quarterly Earnings Results, Misses Expectations By $0.36 EPS

Market Beat·
US
VERA
-3.20%
US
LABD
+2.41%
US
IBBQ
+0.07%
Market Beat·
US
VERA
-3.20%
US
LABD
+2.41%
US
IBBQ
+0.07%

Vera Therapeutics (VERA) Gets a Buy from LifeSci Capital

Tip Ranks·
US
VERA
-3.20%
US
FBT
+0.54%
US
IBBQ
+0.07%
Tip Ranks·
US
VERA
-3.20%
US
FBT
+0.54%
US
IBBQ
+0.07%

Vera Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
VERA
-3.20%
Earnings Watch·
US
VERA
-3.20%

New Verana Health AI Agent Boosts Efficiency and Compliance in MIPS Submissions

Unusual Whales·
US
NAVA
0.00%
US
VERA
-3.20%
US
VRNA
0.00%
Unusual Whales·
US
NAVA
0.00%
US
VERA
-3.20%
US
VRNA
0.00%

AMI Asset Management Corp Makes New $1.44 Million Investment in Vera Therapeutics, Inc. $VERA

Market Beat·
US
VERA
-3.20%
US
BBH
+0.68%
US
IXJ
+0.79%
Market Beat·
US
VERA
-3.20%
US
BBH
+0.68%
US
IXJ
+0.79%
© 2026 Longbridge｜Disclaimer